Pharmaceutical composition, injection and preparation method for treating porcine eperythrozoonosis

A technique for porcine attached erythrocytes and injection, which is applied in the directions of drug combination, extracellular fluid diseases, and pharmaceutical formulations, can solve the problems of short duration, inaccurate curative effect, and high blood concentration, and achieves short course of treatment, significant curative effect, and long-lasting durability. low medicinal effect

Active Publication Date: 2011-12-14
HENAN HUITONG TIANXIA BIO ENG
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

According to many literature reports, tetracycline, oxytetracycline, doxycycline and arsine preparations have obvious inhibitory effects on it. The main drug for treating porcine Eperythrozoonosis is triazamidine, but the blood concentration of triazamidine is high after administration. The curative effect is better when used in the early stage of pig disease, the duration is short, the preventive effect is poor, and the curative effect on pigs with chronic infection or severe symptoms is not exact, and there is relapse in the cured pigs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition, injection and preparation method for treating porcine eperythrozoonosis
  • Pharmaceutical composition, injection and preparation method for treating porcine eperythrozoonosis
  • Pharmaceutical composition, injection and preparation method for treating porcine eperythrozoonosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] 1. The pharmaceutical composition for the treatment of porcine eperythrozoonosis consists of the following components by weight percentage:

[0041] Midazolium Hydrochloride 17%

[0042] Doxycycline Hydrochloride 17%

[0043] Analgin 65%

[0044] Dexamethasone Sodium Phosphate 1%.

[0045] 2. The injection for the treatment of porcine eperythrozoonosis, the injection consists of the following components by weight percentage:

[0046] Midazolium Hydrochloride 5%

[0047] Doxycycline Hydrochloride 5%

[0048] Analgin 20%

[0049] Dexamethasone Sodium Phosphate 0.3%

[0050] Magnesium Chloride 0.5%

[0051] Sodium bisulfite 0.2%

[0052] Disodium EDTA 0.02%

[0053] Propylene Glycol 5%

[0054] The balance is water for injection.

[0055] 3. The preparation method of the injection for the treatment of porcine eperythrozoonosis is carried out in the following steps:

[0056] (1) Take an appropriate amount of water for injection, dissolve magnesium chloride, add ...

Embodiment 2

[0060] 1. The pharmaceutical composition for the treatment of porcine eperythrozoonosis consists of the following by weight percentage:

[0061] Midazolium Hydrochloride 25%

[0062] Doxycycline Hydrochloride 28%

[0063] Aspirin 45%

[0064] Cortisone 2%.

[0065] 2. The injection for the treatment of porcine eperythrozoonosis, the injection consists of the following components by weight percentage:

[0066] Midazolium Hydrochloride 7%

[0067] Doxycycline Hydrochloride 8%

[0068] Aspirin 13%

[0069] Cortisone 0.5%

[0070] Magnesium Chloride 1%

[0071] Sodium bisulfite 0.12%

[0072] Calcium Disodium EDTA 0.01%

[0073] Propylene Glycol 10%

[0074] The balance is water for injection.

[0075] 3. The preparation method of the injection for the treatment of porcine eperythrozoonosis is carried out in the following steps:

[0076] (1) Take an appropriate amount of water for injection, dissolve magnesium chloride, add sodium bisulfite and disodium edetate to diss...

Embodiment 3

[0080] 1. The pharmaceutical composition for the treatment of porcine eperythrozoonosis consists of the following by weight percentage:

[0081] Midazolium Hydrochloride 35%

[0082] Doxycycline Hydrochloride 35%

[0083] Magnesium Salicylate 29.8%

[0084] Prednisone 0.2%.

[0085] 2. The injection for the treatment of porcine eperythrozoonosis, the injection consists of the following components by weight percentage:

[0086] Midazolium Hydrochloride 10%

[0087] Doxycycline Hydrochloride 10%

[0088] Magnesium Salicylate 8.5%

[0089] Prednisone 0.05%

[0090] Magnesium Chloride 2%

[0091] Sodium metabisulfite 0.15%

[0092] Disodium EDTA 0.03%

[0093] Propylene Glycol 15%

[0094] The balance is water for injection.

[0095] 3. The preparation method of the injection for the treatment of porcine eperythrozoonosis is carried out in the following steps:

[0096] (1) Take an appropriate amount of water for injection, dissolve magnesium chloride, add sodium metabi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A pharmaceutical composition for treating porcine eperythrozoonosis, an injection and a preparation method thereof. The pharmaceutical composition comprises imidazuron hydrochloride, doxycycline hydrochloride, non-steroidal anti-inflammatory drugs, glucocorticoids and salts thereof. The injection consists of the following components by weight percentage: 5-15% of imidazolium hydrochloride, 5-10% of doxycycline hydrochloride, 2-20% of non-steroidal anti-inflammatory drugs, 0.05% of glucocorticoids and their salts ~0.5%, magnesium chloride 0.5~5%, antioxidant 0.1~0.2%, metal complexing agent 0.01~0.05%, propylene glycol 5~20%, and the balance is water for injection. The product of the invention is characterized in that the composition of the prescription is reasonable, the physical and chemical properties of the medicine are stable, the dosage is accurate, the onset of action is fast, the maintenance time of the medicine effect is long, the bioavailability is high, the use is safe, and the curative effect is definite.

Description

technical field [0001] The invention relates to a veterinary drug, in particular to a pharmaceutical composition, an injection and a preparation method thereof for treating porcine eperythrozoonosis. Background technique [0002] Eperythrozoonosis is a disease characterized by decreased hematocrit, decreased hemoglobin concentration, leukocytosis, anemia, jaundice and fever, which are parasitic on the surface of red blood cells, plasma and bone marrow by Eperythrozoons. zoonoses. Eperythrozoon infection in pigs is generally a recessive infection, mostly under the action of stress factors. The clinical symptoms of sick pigs are mainly manifested as lack of energy, anorexia, elevated body temperature, anemia and jaundice. According to reports, the mortality rate of piglets can be as high as 90%. The disease can occur all year round, mainly in warm and humid seasons, and it is mostly of natural origin and has a strong prevalence. It can generally pass through 5 ways: digestiv...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/65A61K31/4178A61K45/06A61P7/00
Inventor 张要齐张新蕾
Owner HENAN HUITONG TIANXIA BIO ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products